Symposium Presentation 16.2
Methylphenidate Hydrochloride Modified Release in Adults with ADHD: Self-Rated, Observer-Rated, and Physician-Rated Assessments Show Consistently Significant Improvement Compared to Placebo
Thursday, October 24, 2013 8:30 AM
Michael Huss, MD, Department of Child and Adolescent Psychiatry, University of Medicine, Mainz, Germany
Ylva Ginsberg, MD, PhD, Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden
Torbjorn Tvedten, MD, Centre for Therapy and Supervision, Skien, Norway
Torben Arngrim, MD, Ciconia Aarhus Private Hospital, Aarhus, Denmark
Daniel Gruener, MD, CRI Lifetree, Huntingdon Valley
Alexandra Philipsen, MD, Department of Psychiatry and Psychotherapy, University Medical Center Freiburg, Freiburg, Germany
Preetam Gandhi, Novartis Healthcare Private Limited, Hyderabad, India
Chien-Wei Chen, Novartis Pharmaceutical Corporation, East Hanover, NJ
Vinod Kumar, MD, Novartis Pharmaceutical Corporation, East Hanover, NJ
